ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 351521 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 351521; 2) Community: the network communities that were significantly associated with the response to NSC 351521; 3) Molecule: the relationships between components within communities and NSC 351521; 4) MDR: the compounds that were significantly associated with the NSC 351521.

NSC Compound Enrichment Correlation
NSC 706190 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- 0.00433056621075589 0.31543773
NSC 709969 Null 0.00433056621075589 0.44754272
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.00433056621075589 0.44549644
NSC 757306 Pyrimethamine (USAN) 0.00433056621075589 0.63811304
NSC 114346 Null 0.00567322425730621 0.31579339
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.00567322425730621 0.45606097
NSC 244404 Null 0.00567322425730621 0.35285105
NSC 303861 L-Cysteine analog 0.00567322425730621 0.53770457
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00567322425730621 0.54670799
NSC 33570 Null 0.00567322425730621 0.35990531
Total:89  Current:15    [First] [Prev] [Next] [Last]